Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal‐ and luminal‐like breast cancer xenograftsEvita M. Lindholm(Oslo University Hospital), Olav Engebraaten(Oslo University Hospital)Molecular OncologyMarch 31, 201210.1016/j.molonc.2012.03.006Cited by 21SaveCiteExport RISWatch citationsRelated PapersRAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer|medRxiv|2021|1